Raymond James & Associates’s iShares iBonds Dec 2024 Term Corporate ETF IBDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$12.7M Sell
503,195
-255,086
-34% -$6.41M 0.01% 1081
2024
Q2
$19.1M Sell
758,281
-15,298
-2% -$383K 0.01% 804
2024
Q1
$19.4M Sell
773,579
-1,408
-0.2% -$35.2K 0.01% 793
2023
Q4
$19.3M Sell
774,987
-26,217
-3% -$650K 0.01% 759
2023
Q3
$19.8M Buy
801,204
+24,905
+3% +$614K 0.02% 686
2023
Q2
$19.1M Sell
776,299
-1,938
-0.2% -$47.7K 0.02% 713
2023
Q1
$19.1M Buy
778,237
+205,286
+36% +$5.04M 0.02% 696
2022
Q4
$14M Buy
572,951
+78,355
+16% +$1.91M 0.01% 823
2022
Q3
$12M Buy
494,596
+25,657
+5% +$633K 0.01% 869
2022
Q2
$11.6M Buy
468,939
+105,223
+29% +$2.62M 0.01% 896
2022
Q1
$9.13M Buy
363,716
+57,766
+19% +$1.47M 0.01% 1119
2021
Q4
$7.93M Sell
305,950
-31,571
-9% -$822K 0.01% 1239
2021
Q3
$8.87M Buy
337,521
+3,104
+0.9% +$81.7K 0.01% 1124
2021
Q2
$8.82M Buy
334,417
+7,905
+2% +$209K 0.01% 1146
2021
Q1
$8.62M Sell
326,512
-64,182
-16% -$1.7M 0.01% 1114
2020
Q4
$10.4M Buy
390,694
+25,877
+7% +$685K 0.01% 931
2020
Q3
$9.65M Buy
364,817
+21,787
+6% +$577K 0.01% 874
2020
Q2
$9.04M Buy
343,030
+73,337
+27% +$1.89M 0.01% 871
2020
Q1
$6.67M Buy
269,693
+26,386
+11% +$671K 0.01% 910
2019
Q4
$6.25M Buy
243,307
+86,526
+55% +$2.22M 0.01% 1131
2019
Q3
$4.03M Sell
156,781
-16,706
-10% -$427K 0.01% 1347
2019
Q2
$4.42M Buy
173,487
+33,292
+24% +$832K 0.01% 1282
2019
Q1
$3.49M Buy
140,195
+20,503
+17% +$500K 0.01% 1404
2018
Q4
$2.86M Buy
119,692
+14,936
+14% +$356K 0.01% 1421
2018
Q3
$2.52M Buy
104,756
+46,771
+81% +$1.13M ﹤0.01% 1672
2018
Q2
$1.4M Buy
57,985
+19,163
+49% +$462K ﹤0.01% 1990
2018
Q1
$947K Buy
38,822
+27,672
+248% +$680K ﹤0.01% 2171
2017
Q4
$279K Buy
11,150
+1,185
+12% +$29.8K ﹤0.01% 2879
2017
Q3
$251K Sell
9,965
-621
-6% -$15.6K ﹤0.01% 2903
2017
Q2
$265K Buy
+10,586
New +$264K ﹤0.01% 2806

Other funds holding IBDP

Raymond James & Associates's IBDP Position: Q3 2024 in Review

Raymond James & Associates reduced its iShares iBonds Dec 2024 Term Corporate ETF (IBDP) stake by 34% in Q3 2024, selling an estimated $6.41M and leaving 503,195 shares worth $12.7M. The position accounts for 0.01% of the portfolio, ranked #1081.

Raymond James & Associates first reported a position in IBDP in Q2 2017 and has held it in 30 quarters since. The position peaked at $19.8M in Q3 2023. 333 funds tracked by Wall St. Rank hold IBDP as of Q3 2024.

  • Raymond James & Associates held 503,195 shares of iShares iBonds Dec 2024 Term Corporate ETF worth $12.7M as of Q3 2024.
  • Raymond James & Associates sold 255,086 iShares iBonds Dec 2024 Term Corporate ETF shares in Q3 2024, an estimated $6.41M.
  • iShares iBonds Dec 2024 Term Corporate ETF made up 0.01% of Raymond James & Associates's portfolio in Q3 2024, its #1081 holding.
  • Raymond James & Associates first reported a position in iShares iBonds Dec 2024 Term Corporate ETF in Q2 2017 and has held it in 30 quarters since.
  • Raymond James & Associates's iShares iBonds Dec 2024 Term Corporate ETF position peaked at $19.8M in Q3 2023.
  • 333 funds tracked by Wall St. Rank held iShares iBonds Dec 2024 Term Corporate ETF as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.